Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Digestive Health Products Market

ID: MRFR/FnB/1879-HCR
110 Pages
Tejas Chaudhary
Last Updated: May 02, 2026

消化健康产品市场研究报告按产品类型(益生元、益生菌、多种维生素、乳糖酶营养补充剂、消化营养补充剂)、按交付形式(胶囊、片剂、咀嚼片、滴剂、胶囊片、棒)、按应用(功能食品、功能饮料、早餐谷物、补充剂、药品)和按地区(北美、欧洲、亚太地区和其他地区)世界)——2032 年之前的市场预测

分享
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Digestive Health Products Market Infographic
Purchase Options

全球消化健康产品市场概览

p2023 年,消化健康产品市场规模价值 221 亿美元。预计消化健康产品行业将从 2024 年的 235.8 亿美元增长到 2032 年的 347.9 亿美元,预测期内(2024 - 2032 年)的复合年增长率 (CAGR) 为 6.7%。消化健康产品用于治疗胃肠道疾病,因为它们没有任何负面副作用。因此,由于这些消化产品成本低且安全,其日益普及将使市场受益。这些产品在医学和某些医疗条件下的使用量不断增加,也将推动消化健康产品市场的发展,从而推动消化健康产品的增长。这些只是推动市场发展的部分因素。

消化健康产品市场概览

来源:二手资料研究、一手资料研究、MRFR 数据库和分析师评论

消化健康产品市场趋势

ul
  • 人们健康意识的增强推动市场增长

p益生菌对于维持健康的肠道菌群至关重要,在追求整体健康生活方式的西方消费者中越来越受欢迎。因此,随着消费者对肠道健康的认识不断提高,预计在预测期内,对消化健康产品的需求将会上升。在预测期内,预计美国对消化健康的需求将大幅增加。由于不良的饮食习惯和大量食用加工食品、高钠食品和即食食品,肥胖、消化系统疾病和生活方式相关疾病的患病率预计会增加,从而推动美国对消化健康产品的需求。因此,这个因素正在推动市场复合年增长率。​​p

脂肪酶、淀粉酶和乳糖酶是一些有助于维持健康胃酸水平和增强消化的消化健康产品酶。促进消化健康产品市场发展的主要因素之一是营养食品添加剂和营养补充剂的需求不断增长。预计乳制品行业对牛奶、奶酪、酸奶和饮料等消化健康产品的需求将大幅增加。由于益生菌和食品酶在新生儿配方奶粉中的使用不断扩大,以及成年人对健康的日益关注,这些产品预计将在未来几年推动市场增长。因此,预计这将加速全球消化健康产品行业的收入增长。

细分市场洞察

h3消化健康产品产品类型洞察 p消化健康产品市场根据产品类型细分,包括益生元、益生菌、复合维生素、乳糖酶营养补充剂和消化营养补充剂。益生元细分市场在2022年的消化健康产品行业数据中占据了大部分份额。这是因为人们对益生菌的健康益处有了更深入的了解,包括减少过敏原和炎症、治疗和预防腹泻、预防肠易激综合征 (IBS) 以及增强免疫系统。北美和欧洲的许多企业,包括 ADM、嘉吉公司和 BENEO GmBH,都生产益生元成分并出口到其他国家。由于天然益生元草药的采集和种植增加,尤其是在北美和欧洲,益生元预计将在各种应用中得到更频繁的使用。

消化健康产品交付形式洞察

p根据交付形式,消化健康产品市场细分包括胶囊、片剂、咀嚼片、滴剂、囊片和棒状剂。胶囊细分市场在2022年占据了市场增长的主导地位,预计在2022-2030年的预测期内,胶囊细分市场将增长更快。由于胶囊剂型相较于其他剂型具有诸多优势,例如给药速度快、使用便捷以及口味顾虑较少,胶囊类别目前在市场上占据了垄断地位。预计其复合年增长率将达到最高。这些因素预计将推动该细分市场的发展,从而促进消化健康产品的增长。

图2:2022年及以后消化健康产品市场(按交付形式划分) 2030 年(十亿美元)消化健康产品市场,按交付形式划分,2022 年和 2030 年(十亿美元)

来源:二手资料研究、一手资料研究、MRFR 数据库和分析师评论

消化健康产品应用洞察

p基于应用的消化健康产品市场细分包括功能性食品、功能性饮料、早餐谷物、补充剂和药品。2022年,功能性饮料在消化健康产品市场中占据了主要份额。日益增长的消费者偏好推动了预防性保健市场的发展,并为乳制品创造了有效的益生菌菌株,以减少肠道炎症、增强肠道健康并提升免疫力。康普茶、运动饮料和放松饮料等功能性饮料因其独特的风味和健康优势而广受欢迎。因此,预计益生元和益生菌等功能性成分在非酒精饮料中的应用将会增加,从而促进市场扩张。

消化健康产品区域洞察

p按地区划分,本研究提供了北美、欧洲、亚太地区和世界其他地区的市场洞察。 2022年,北美消化健康产品市场规模达101.21亿美元,市场份额约为45.80%,预计在研究期内将呈现显著的复合年增长率。该地区较高的市场份额得益于其领先企业的强大影响力、政府对新产品开发的扶持以及益生菌和益生元领域的技术进步。此外,医疗成本上涨、食品法规修改对标签和产品声明的影响、科学和加工技术的快速进步、老年人口的增加以及消费者对通过饮食实现健康的兴趣日益浓厚等因素,正在推动北美消费者对消化健康产品的兴趣。新产品开发、合作伙伴关系、合作关系、扩张、合并和收购是市场组织使用的主要策略。

此外,市场报告中研究的主要国家是:美国、加拿大、德国、法国、英国、意大利、西班牙、中国、日本、印度、澳大利亚、韩国和巴西。

图 3:2022 年各地区消化保健产品市场份额(%)

2022 年各地区消化保健产品市场份额(%)

来源:二手研究,一手研究,

MRFR 数据库和分析师评论

欧洲消化保健产品市场占据第二大市场份额。由于行业成熟度,德国和英国等大型市场对消化保健产品的高需求将对市场增长产生积极影响,尽管速度较慢。此外,英国消化保健产品市场占有最大的市场份额,而德国消化保健产品行业是该地区增长最快的市场。

预计亚太地区消化保健产品市场在 2022 年至 2030 年期间的复合年增长率将最快。消化保健产品在中国、澳大利亚、韩国等国家的广泛使用可以解释这一点。由于城市水培农场的出现,预计中国和印度的市场将在预测期内显着增长。由于北美拥有众多企业,因此具有巨大的增长潜力。此外,中国消化保健产品市场占有最大的市场份额,而印度消化保健产品市场是该地区增长最快的市场。

 消化保健产品主要市场参与者及竞争洞察

主要市场参与者正在投入大量资金进行研发,以扩大其产品线,这将有助于消化保健产品市场进一步增长。市场参与者还采取了一系列战略举措来扩大其全球影响力,关键的市场发展包括新产品发布、并购、合同协议、增加投资以及与其他组织的合作。消化保健产品行业的竞争对手必须提供具有成本效益的产品,才能在竞争日益激烈、不断发展的市场环境中扩张和生存。

消化保健产品行业制造商为客户谋福利并扩大市场部门而采用的主要商业策略之一是本地生产以降低运营成本。近年来,消化保健产品行业为医药行业带来了一些最重要的益处。消化健康产品市场的主要参与者包括丹尼斯克股份公司、达能公司、雀巢公司、养乐多本社株式会社、Arla Foods Inc. 和 BioGaia AB。

一家名为国际香精香料公司的美国公司生产调味剂、香水和化妆品成分,销往世界各地。其总部位于纽约市,在 44 个国家设有生产、销售和创意中心。该公司是标准普尔 500 指数的成分股。国际香精香料公司 (IFF) 于 2021 年 6 月在美国推出了一种用于乳制品的新型酶 Nurica。

领先的生物技术和营养公司 PanTheryx 致力于在国际上商业化基于牛初乳的健康产品。该公司致力于利用大自然超级食品的力量,创造改善人类和动物健康的突破性方法。这涵盖了从将我们定位为全球顶级初乳供应商到推进尖端研究和商业化创新解决方案的方方面面。PanTheryx Inc. 于 2021 年 3 月宣布已从拜耳医疗保健有限公司 (Bayer HealthCare LLC) 收购了商标和益生菌补充剂品牌 TruBiotics。TruBiotics 品牌与 PanTheryx 现有的品牌和成分产品(包括 Life's First Natural、乳初乳和益生元)相结合,打造了一系列营养补充剂,旨在促进生命各个阶段的全面消化和免疫健康。

消化健康产品市场的主要公司包括

    • 丹尼斯克公司
    • 达能公司
    • 雀巢公司
    • 养乐多本社有限公司
    • 阿拉食品公司
    • 拉勒曼
    • 汉森控股
    • 嘉吉公司
    • 雅培实验室

消化保健产品行业发展

2022 年 2 月:

2021年9月:

消化健康产品市场细分

消化健康产品类型展望(十亿美元,2018-2030 年)

    • 益生元
    • 益生菌
    • 复合维生素
    • 乳糖酶营养补充剂
    • 消化营养补充剂

消化健康产品交付形式展望(十亿美元, 2018-2030)

    • 胶囊
    • 片剂
    • 咀嚼片
    • 滴剂
    • 胶囊
    • 棒状剂

消化健康产品应用展望(十亿美元,2018-2030)

    • 功能性食品
    • 功能性饮料
    • 早餐谷物
    • 补充剂
    • 药品

消化健康产品区域展望(美元十亿,2018-2030)

    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 德国
      • 法国
      • 英国
      • 意大利
      • 西班牙
      • 欧洲其他地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 南韩国
      • 澳大利亚
      • 亚太地区其他地区
    • 世界其他地区
      • 中东
      • 非洲
      • 拉丁美洲

市场亮点

FAQs

What is the projected market valuation for The Global Digestive Health Products in 2035?

The projected market valuation for The Global Digestive Health Products in 2035 is 48.22 USD Billion.

What was the market valuation for The Global Digestive Health Products in 2024?

The overall market valuation for The Global Digestive Health Products was 23.58 USD Billion in 2024.

What is the expected CAGR for The Global Digestive Health Products from 2025 to 2035?

The expected CAGR for The Global Digestive Health Products during the forecast period 2025 - 2035 is 6.72%.

Which companies are considered key players in The Global Digestive Health Products?

Key players in the market include Nestle, Procter & Gamble, Danone, Unilever, Abbott Laboratories, Bayer AG, Kraft Heinz, Reckitt Benckiser, and GSK.

What are the projected values for the Prebiotics segment by 2035?

The projected value for the Prebiotics segment is expected to reach 6.0 USD Billion by 2035.

How does the market for Digestive Nutritional Supplements compare to other segments?

The Digestive Nutritional Supplements segment had a valuation of 20.22 USD Billion projected for 2035, indicating strong market performance.

What delivery format is expected to have the highest valuation in 2035?

The Tablets delivery format is projected to reach a valuation of 12.0 USD Billion by 2035, making it the highest among delivery formats.

What is the expected growth for Functional Foods in The Global Digestive Health Products?

The Functional Foods segment is projected to grow to 16.0 USD Billion by 2035, reflecting a robust demand.

What is the anticipated value of the Probiotics segment by 2035?

The Probiotics segment is anticipated to reach a value of 10.0 USD Billion by 2035.

How does the market for Pharmaceuticals in digestive health products compare to other applications?

The Pharmaceuticals application is projected to grow to 6.22 USD Billion by 2035, indicating a smaller yet significant market presence.
作者
Author
Author Profile
Tejas Chaudhary
Research Analyst Level II
I have a degree in Engineering (Civil), with masters in Business Administration (Marketing). With more than 4 years of experience in market research and consulting, I am involved in end-to-end process of market research, proposals, project kickoffs and delivery. I have research knowledge and expertise in consumer goods/packaging domain. Also I have worked for various other domains like construction & equipment. Effectively managed and delivered more than 60 report studies for regional as well as global clientele.
发表评论

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed nutritional and gastroenterology journals, clinical publications, and authoritative food & health organizations. Key sources included the US Food & Drug Administration (FDA), European Food Safety Authority (EFSA), Food and Agriculture Organization of the United Nations (FAO), World Health Organization (WHO) Department of Nutrition and Food Safety, National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Center for Biotechnology Information (NCBI/PubMed), International Probiotics Association (IPA), Council for Responsible Nutrition (CRN), International Scientific Association for Probiotics and Prebiotics (ISAPP), American Gastroenterological Association (AGA), European Society for Clinical Nutrition and Metabolism (ESPEN), USDA Agricultural Research Service, Health Canada, Food Standards Australia New Zealand (FSANZ), Japan Ministry of Health Labour and Welfare (MHLW), and Euromonitor International Packaged Food Database.

These sources were employed to gather consumption statistics, GRAS (Generally Recognized as Safe) notification data, clinical efficacy studies on probiotic strains, microbiome research, demographic dietary trends, and regulatory landscape analysis for prebiotics, probiotics, digestive enzymes, and nutritional supplements.

 

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consisted of CEOs, VPs of Research & Development, regulatory compliance chiefs, and commercial directors from probiotic manufacturers, functional food & beverage companies, and dietary supplement OEMs. Board-certified gastroenterologists, clinical nutritionists, registered dietitians, pharmacy procurement leads, retail category managers for health & wellness, and food service directors from hospitals and healthcare institutions comprised demand-side sources. Market segmentation was validated across delivery formats (capsules, tablets, chewables, drops) through primary research. Additionally, product pipeline timelines for novel probiotic formulations were confirmed, and consumer adoption patterns, pricing strategies for premium digestive SKUs, and distribution channel dynamics were surveyed.

Primary Respondent Breakdown:

By Designation: C-level Executives (28%), Director Level (32%), Manager Level/Others (40%)

By Region: North America (42%), Europe (25%), Asia-Pacific (22%), Rest of World (11%)

 

Market Size Estimation

Revenue mapping and consumption volume analysis were employed to determine the global market valuation for functional foods, beverages, and supplements. The methodology comprised the following:

Identification of 55+ main manufacturers and ingredient suppliers in North America, Europe, Asia-Pacific, and Latin America, including specialized probiotic culture houses and enzyme producers

Product mapping of prebiotics (inulin, FOS, GOS), probiotics (Lactobacillus, Bifidobacterium strains), digestive enzymes (lactase, lipase, amylase), and multivitamin formulations

Examination of the estimated SKU-level performance and reported annual revenues that are specific to digestive health portfolios, including private label and branded segments

Coverage of manufacturers that account for 75-80% of the global market share in 2024, with a particular focus on dairy-based probiotic leaders and fermentation technology providers

For pharmaceuticals, functional beverages, and breakfast cereals applications, segment-specific valuations are derived through extrapolation using bottom-up (retail consumption volume × average retail price by country, adjusted for trade margins) and top-down (manufacturer revenue validation and import/export trade data) approaches.

下载免费样本

请填写以下表格以获取本报告的免费样本

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions